The objective of this proposal is to isolate and characterize genes encoding serine esterases (SEs) from human natural killer (NK) and cytotoxic T-lymphocytes (CTL) in order to investigate the role of these molecules in cellular cytotoxicity. The mechanisms by which NK cells and CTLs destroy their cellular targets is of fundamental importance for our understanding of cell mediated immunity. Cell killing involves contact and binding between killer and target cells followed in most instances by secretion of the contents of large cytoplasmic granules from mature cytotoxic lymphocytes. These granules contain several polypeptides with potential involvement in cytolysis including a pore-forming protein, perforin, another cytotoxin which is antigenically related to tumor necrosis factor and lymphotoxin, nucleolytic factor(s) as well as several different serine proteases (SEs). The functions of SEs in cytotoxic cells are unknown, but one possibility is that they may constitute an intracellular activation pathway for other cytotoxic molecules (e.g., perforin) analogous to that seen extracellularly with the SEs of the complement pathway. So far, as many as eight different but structurally related SEs have been isolated from murine cytotoxic lymphocytes, however, little if any information is available regarding the corresponding molecules in man. Thus we propose to: #1) Clone and characterize cDNA and genomic clones encoding SEs from human NK cells and CTLs; #2) characterize SE proteins using prokaryotic expression vectors, purify hybrid proteins and produce rabbit antisera; #3) Investigate expression of SE genes in human lymphocyte subsets, their differential expression during activation of cytotoxic and non-cytotoxic lymphocytes, and factors involved in the regulation of these genes; #4) Express individual SE in a biologically active form for detailed functional studies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA049096-03
Application #
3193047
Study Section
Experimental Immunology Study Section (EI)
Project Start
1989-07-01
Project End
1992-06-30
Budget Start
1991-07-01
Budget End
1992-06-30
Support Year
3
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Geisberg, M; Terry, L A; Flomenberg, N et al. (1992) Cytotoxic and proliferative allospecific T-cell clones contain perforin and mediate anti-CD3-induced cytotoxicity. Hum Immunol 35:239-45
Goldbach-Mansky, R; King, P D; Taylor, A P et al. (1992) A co-stimulatory role for CD28 in the activation of CD4+ T lymphocytes by staphylococcal enterotoxin B. Int Immunol 4:1351-60
Selvakumar, A; Mohanraj, B K; Eddy, R L et al. (1992) Genomic organization and chromosomal location of the human gene encoding the B-lymphocyte activation antigen B7. Immunogenetics 36:175-81
Trapani, J A; Browne, K A; Dawson, M J et al. (1992) A novel gene constitutively expressed in human lymphoid cells is inducible with interferon-gamma in myeloid cells. Immunogenetics 36:369-76
Geisberg, M; Dupont, B (1992) Cytolytic effector function is present in resting peripheral T lymphocytes. Int Immunol 4:1273-81
Trapani, J A; Kwon, B S; Kozak, C A et al. (1990) Genomic organization of the mouse pore-forming protein (perforin) gene and localization to chromosome 10. Similarities to and differences from C9. J Exp Med 171:545-57
Geisberg, M; Trapani, J A; Dupont, B (1990) Monoclonal antibodies detecting discrete epitopes of human perforin. Tissue Antigens 35:229-33
Trapani, J A; Dupont, B (1990) Novel putative promoter/enhancer sequences are shared by the mouse and human perforin (Pfp) genes. Tissue Antigens 36:228-34
Klein, J L; Selvakumar, A; Trapani, J A et al. (1990) Characterization of a novel, human cytotoxic lymphocyte-specific serine protease cDNA clone (CSP-C). Tissue Antigens 35:220-8